Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Construction in Progress (2017 - 2018)

Abeona Therapeutics has reported Construction in Progress over the past 2 years, most recently at $409000.0 for Q4 2018.

  • Quarterly results put Construction in Progress at $409000.0 for Q4 2018, down 10.11% from a year ago — trailing twelve months through Dec 2018 was $409000.0 (down 10.11% YoY), and the annual figure for FY2018 was $409000.0, down 10.11%.
  • Construction in Progress for Q4 2018 was $409000.0 at Abeona Therapeutics, down from $455000.0 in the prior quarter.
  • Over the last five years, Construction in Progress for ABEO hit a ceiling of $455000.0 in Q4 2017 and a floor of $409000.0 in Q4 2018.